Per­cep­tive hits the pric­ing sweet spot on its lat­est SPAC, kick­start­ing the search for next for­ev­er part­ner

If you can say one thing about big-name biotech in­vestor Per­cep­tive Ad­vi­sors, it’s this: It knows where its pock­et is.

Af­ter pric­ing four sep­a­rate SPACs — all un­der the “Arya” moniker — right around the $130 mil­lion mark for their pub­lic of­fer­ings, Per­cep­tive is back again with the launch of its fifth fund, al­so priced in the sweet spot at $130 mil­lion.

Arya V, as it is known, will be chaired by Per­cep­tive CEO Joseph Edel­man with Adam Stone helm­ing the ship and Michael Alt­man, a man­ag­ing di­rec­tor at Per­cep­tive, han­dling fi­nance. The SPAC will tar­get North Amer­i­can and Eu­ro­pean life sci­ences and med­ical tech­nol­o­gy com­pa­nies in the $300 mil­lion to $500 mil­lion range with the po­ten­tial for $1 bil­lion or more in mar­ket cap, Per­cep­tive said in a re­lease.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER